Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Gabrielson

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 4, 2003
A neural survival factor is a candidate oncogene in breast cancerDale Porter, Stanislawa Weremowicz, Koei Chin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2013
Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancerVered Stearns, Lisa K Jacobs, Maryjo Fackler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2020
NRF2 Activation Promotes Aggressive Lung Cancer and Associates with Poor Clinical OutcomesAnju Singh, Anneleen Daemen, Dorothee Nickles, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 16, 2018
De novo lipogenesis represents a therapeutic target in mutant Kras non-small cell lung cancerAnju Singh, Christian Ruiz, Kavita Bhalla, et al.
Oncogene|August 3, 2021
CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancerYu Yan, Athira Narayan, Soonweng Cho, et al.
Breast Cancer Research : BCR|December 5, 2024
Multimodal genome-wide survey of progressing and non-progressing breast ductal carcinoma in-situMarija Debeljak, Soonweng Cho, Bradley M Downs, et al.
Nature Medicine|October 30, 2023
Association between pathologic response and survival after neoadjuvant therapy in lung cancerJulie Stein Deutsch, Ashley Cimino-Mathews, Elizabeth Thompson, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 26, 2024
Concordance of Whole-Slide Imaging and Conventional Light Microscopy for Assessment of Pathologic Response Following Neoadjuvant Therapy for Lung CancerJulie S Deutsch, Daphne Wang, Krista Y Chen, et al.
Nature Communications|September 24, 2014
Activation of diverse signalling pathways by oncogenic PIK3CA mutationsXinyan Wu, Santosh Renuse, Nandini A Sahasrabuddhe, et al.
ACS Chemical Biology|August 24, 2016
Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC TumorsAnju Singh, Sreedhar Venkannagari, Kyu H Oh, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Proceedings of the National Academy of Sciences of the United States of America|September 4, 2003
A neural survival factor is a candidate oncogene in breast cancerDale Porter, Stanislawa Weremowicz, Koei Chin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2013
Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancerVered Stearns, Lisa K Jacobs, Maryjo Fackler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2020
NRF2 Activation Promotes Aggressive Lung Cancer and Associates with Poor Clinical OutcomesAnju Singh, Anneleen Daemen, Dorothee Nickles, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 16, 2018
De novo lipogenesis represents a therapeutic target in mutant Kras non-small cell lung cancerAnju Singh, Christian Ruiz, Kavita Bhalla, et al.
Oncogene|August 3, 2021
CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancerYu Yan, Athira Narayan, Soonweng Cho, et al.
Breast Cancer Research : BCR|December 5, 2024
Multimodal genome-wide survey of progressing and non-progressing breast ductal carcinoma in-situMarija Debeljak, Soonweng Cho, Bradley M Downs, et al.
Nature Medicine|October 30, 2023
Association between pathologic response and survival after neoadjuvant therapy in lung cancerJulie Stein Deutsch, Ashley Cimino-Mathews, Elizabeth Thompson, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 26, 2024
Concordance of Whole-Slide Imaging and Conventional Light Microscopy for Assessment of Pathologic Response Following Neoadjuvant Therapy for Lung CancerJulie S Deutsch, Daphne Wang, Krista Y Chen, et al.
Nature Communications|September 24, 2014
Activation of diverse signalling pathways by oncogenic PIK3CA mutationsXinyan Wu, Santosh Renuse, Nandini A Sahasrabuddhe, et al.
ACS Chemical Biology|August 24, 2016
Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC TumorsAnju Singh, Sreedhar Venkannagari, Kyu H Oh, et al.
Pageof 14